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In recent decades; scientists have provided encouraging evidence that probiotic microorganisms
are valuable in the prevention and treatment of a variety of diseases. The use of probiotics is expanding
dramatically because of our growing understanding of how these beneficial microorganisms exert
their effects and which strains are effective for specific conditions.
Several beneficial effects have been attributed to probiotic consumption in clinical trials as well
as in vitro and in vivo experimental models. One interesting example is an application of these
microorganisms as a non-pharmaceutical approach to help manage human metabolic disorders [1].
In this regard, research from several laboratories around the word has demonstrated that the regular
consumption of probiotics is able to improve the serum lipid profile, in particular by reducing serum
cholesterol levels. Moreover, scientists have shown that the hypocholesterolaemic effect of probiotics
could be explained by different mechanisms that include: decreased absorption of intestinal cholesterol,
deconjugation of bile salts; modulation of lipid metabolism through changes in cytokine and adipokine
profiles, incorporation or assimilation of cholesterol in the bacterial membrane, and inhibition of
the expression of the intestinal cholesterol transporters [1]. More recently, the search for beneficial
effects of probiotics on metabolism has moved to the modulation of serum uric acid levels. It is well
known that the excessive intake of purine-rich foods such as animal and fish meats that contain
high amounts of inosine and its related purines is crucial for the increase of serum uric acid levels.
Few reports have investigated the effect of probiotics ingestion on hyperuricemia. In this Special Issue
of Microorganisms, Yamada and co-workers explored this field. Those authors previously showed that
Lactobacillus gasseri PA-3 incorporates adenosine and its related purines and that oral treatment with
the PA-3 strain diminished adenosine absorption in rats [2]. Here, they investigated whether L. gasseri
PA-3 also incorporates inosine-monophosphate, inosine, and hypoxanthine, and whether it reduces
their absorption in rats. Interestingly, the work reported that the oral administration of L. gasseri
PA-3 reduced the absorption of the three studied compounds. The PA-3 strain may therefore protect
individuals against elevated serum uric acid levels and could have a positive effect in the reduction of
hyperuricemia and the prevention of gout [3]. They have successfully produced a functional fermented
products based on their studies in Japan.
The expanding knowledge of probiotic effects is also modifying the way in which we see
classical functional foods such as yogurt or kefir. Lactobacillus delbrueckii subspecies bulgaricus
and Streptococcus thermophilus have generally been used as starters for yogurt production. Yogurt
is considered a dairy food carrying viable bacteria with health-promoting effects. In fact,
some immunomodulatory properties have been attributed to yogurt. However, as the efficacy of
probiotics was discovered to be strain-specific, researchers have questioned whether the beneficial
effects of yogurt could be improved by the use of selected L. delbrueckii and S. thermophilus strains
with specific properties [4]. In this regard, it was reported that a yogurt developed with L. delbrueckii
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CRL423 and S. thermophilus CRL412, strains previously selected by their immunomodulatory capacities,
was able to improve respiratory immunity and protect against Streptococcus pneumoniae infection [5].
In this issue Kamiya et al., [6] aimed to evaluate the immunomodulatory activity of two bacterial
strains from yogurt L. delbrueckii ME-552 and S. thermophilus ME-553. By performing in vitro and
in vivo experiments, authors investigated the effect of both strains on T cell function. It was shown that
the oral administration of the ME553 strain to C57BL/6 mice enhanced the amount of IFN-γ and IL-17
produced by CD4+ T cells from Peyer’s patches [6]. These results open the door to interesting future
research in order to develop a probiotic yogurt with the capacity to stimulate mucosal immunity.
Probiotics have been used not only to improve immunity but to modulate excessive or
unproductive inflammation as well. Thereby, probiotics have found a potential place in the
management of inflammatory diseases such as allergies. Intervention studies with probiotics have
demonstrated beneficial effects on allergic sensitization and IgE levels, having an impact on eczema,
wheezing illnesses and asthma [7]. It is well established that mast cells play a critical role in
IgE-mediated allergic diseases, and the degranulation of these cells is important in the pathogenesis of
allergy. The study of Harata et al., [8] evaluated the ability of 23 lactobacilli strains, including strains
isolated from the human intestine, to regulate degranulation of mast cells. The results suggested that
lactobacilli, particularly those from the human intestine, are able to reduce the activation of mast cells
in a strain-dependent manner [8].
In addition to the application of probiotics in the prevention or treatment of different diseases,
great advances have been made in the understanding of the cellular and molecular mechanisms of
probiotic action. Whole-genome sequencing of commensal and probiotic microbes and the study of
microbiota using advanced genomic techniques have allowed us to piece together the relationship
between the host and bacteria within the complex ecosystems of the human body. In this regard,
adhesion of microbes to the mucosal tissues has been considered one of the key initial events in
the successful colonization of the gastrointestinal tract. Therefore, there is considerable interest
in determining the molecular mechanisms that probiotic bacteria use to colonize their host, and a
substantial amount of research has been performed in this filed. As discussed in the review of
Nishiyama, Sugiyama and Mukai [9], probiotic lactobacilli exhibit various adhesive properties on
mucin and mucin-related carbohydrate chains based on a wide variation of molecular structures.
This implies that lactobacilli adapt to the constantly changing intestinal environment of the host,
and further suggests that adhesion factors of these microorganisms possess specific binding affinities
that allow them to colonize the host and avoid competition with other bacteria. Thus, understanding
the interactions between probiotic lactobacilli and mucin is crucial for elucidating the survival strategies
of these bacteria in the gut. The review highlights the characteristics of the interactions between
lactobacilli and mucin, and concomitantly considers the gastrointestinal structure from a histochemical
perspective. Further, biofilm formation has been recently recognized as an important property in
the interaction of probiotics with the host. Numerous investigations have verified the beneficial
effect of probiotic strains in biofilm form, including increased resistance to temperature, gastric pH
and mechanical forces to that of their planktonic counterparts. In addition, the development of new
encapsulation technologies, which have exploited the properties of biofilms in the creation of double
coated capsules, has given origin to fourth generation probiotics. Up to now, reviews have focused on
the detrimental effects of biofilms associated with pathogenic bacteria. On the contrary, the review
of Dr. Garcia and co-workers [10], aimed to amalgamate the information describing the biofilms of
probiotic strains and their role in probiotic functions. In particular, the review highlights that biofilm
formation by probiotic bacteria is considered a beneficial property because it promotes colonization
and longer permanence in the mucosa of the host, avoiding colonization by pathogenic bacteria.
Moreover, the article reviews the development of probiotics using technology inspired by biofilms.
The science of probiotics has proven that some of these beneficial bacteria exert their beneficial
effects on the immune system through several molecules including cell wall, peptidoglycan and
exopolysaccharides (EPS) that are able to interact with specific host cell receptors such as pattern
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recognition receptors. In the review of Laiño et al., [11], the current knowledge of the health-promoting
actions of EPS from probiotic bacteria with special focus on their immunoregulatory actions are
summarized. In addition, the article describes the studies evaluating the molecular interactions of
EPS from probiotics with intestinal epithelial cells, and highlights the role of the pattern recognition
receptors and their signaling pathways in the anti-inflammatory capacities of probiotic EPS. A detailed
molecular understanding should lead to a more rational use of probiotics in general, and their EPS
in particular, as efficient prevention and therapies for specific immune-related disorders in humans
and animals.
The articles presented in this Special Issue investigate several aspects of probiotic interaction
with the host and their beneficial impact on health. We expect that these articles will stimulate new
discussions and investigations to cover the great diversity of probiotics, applications and mechanisms
of action that still need to be addressed.
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